62.2 F
New York
Wednesday, September 30, 2020

The Forecast Just Changed on Novartis AG (NYSE:NVS)

Must read

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) on the Path to Ruin

Titan Pharmaceuticals Inc. (TTNP) shares are trading at lower $0.17 and the avg recommendation for the stock is Moderate Buy. To add more color...

The Unprecedented Rise of TherapeuticsMD Inc. (NASDAQ:TXMD)

TherapeuticsMD Inc. (TXMD) shares are trading at higher $1.61 and the avg recommendation for the stock is Moderate Buy. To add more color to...

Investor Confidence is Falling for CTI BioPharma Corp. (NASDAQ:CTIC)

CTI BioPharma Corp. (CTIC) shares are trading at lower $1.05 and the avg recommendation for the stock is Moderate Buy. To add more color...

The Forecast Just Changed on GSX Techedu Inc. (NYSE:GSX)

GSX Techedu Inc. (GSX) shares are trading at lower $93.98 and the avg recommendation for the stock is Hold, while the current analyst price...

The Novartis AG (NVS) shares are trading at higher $82.43 and the avg recommendation for the stock is Strong Buy. while the current analyst price target stands at $101.00.

To add more color to this target, the company’s high over the last year is $99.84 and the low is $69.18. Over the last 52 weeks, NVS is down -17.44% while the S&P 500 is down -0.83%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, NVS reported a profit of $8.19 billion. Novartis AG also saw revenues increase to $11.62 billion. In addition, NVS has free cash flow of $6.01 billion as of 06-2020. The company’s EBITDA came in at $2.35 billion which compares well with its peers.

NVS booked profit margins of 14.60%, its Return on Equity (ROE) is 13.60%, and its Return on Assets is 6.00%. All told, it is clear that, NVS needs to be on your watchlist.

Find out when NVS reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. NVS has a short ratio of 1.15 and outstanding shares of 2.29B.

Company Outlook

NVS has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.59 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 3.14. Novartis AG NVS also noted assets of $123.76 billion at the end of the last quarter. Investors should also keep an eye on sector updates as NVS has historically followed its peers on positive news.

All told, Novartis AG NVS has strung together solid data and demonstrated underlying fundamentals. At its current valuation, NVS represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Novartis AG NVS is now commanding a market cap of 205.26B and a float of 2.26B. NVS is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of NVS stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in NVS, either long or short, and we have not been compensated for this article.

Latest article

CEMEX S.A.B. de C.V. (NYSE:CX) is Gaining Momentum on Earnings Catalyst

CEMEX S.A.B. de C.V. (CX) shares are trading at lower $3.62 and the avg recommendation for the stock is Moderate Buy, while the current...

The Rejuvenation of New Concept Energy Inc. (AMEX:GBR)

New Concept Energy Inc. (GBR) shares are trading at higher $1.72. To add more color to this target, the company’s high over the last...

BigCommerce Holdings Inc. (NASDAQ:BIGC) Recent Earnings Shows Major Promise

BigCommerce Holdings Inc. (BIGC) shares are trading at higher $87.79 and the avg recommendation for the stock is Hold, while the current analyst price...

The Unprecedented Rise of Jaguar Health Inc. (NASDAQ:JAGX)

Jaguar Health Inc. (JAGX) shares are trading at lower $0.30 and the avg recommendation for the stock is Moderate Buy. To add more color...

ZoomInfo Technologies Inc. (NASDAQ:ZI) Finding Strong Support

ZoomInfo Technologies Inc. (ZI) shares are trading at higher $41.60 and the avg recommendation for the stock is Moderate Buy, while the current analyst...